Document is current
Any future updates will be listed below
-
Authors
Wang, Yun https://orcid.org/0000-0002-5836-0872
Chen, Shuzhao
Liang, Zhijian https://orcid.org/0009-0001-4533-8254
Gale, Robert Peter
Liu, Shutong
Chen, Xiaoqin
Chi, Peidong
Song, Yiling
Zhang, Yingchun
Wang, Weida https://orcid.org/0000-0002-8272-5421
Li, Juan https://orcid.org/0000-0002-0909-4731
Xia, Zhongjun https://orcid.org/0009-0005-8410-2817
Liang, Yang https://orcid.org/0000-0002-4226-9580
Huang, Xiaojun https://orcid.org/0000-0002-2145-6643
- License Information
-
More Information
Article History
Received: 5 March 2025
Revised: 15 June 2025
Accepted: 10 July 2025
First Online: 1 August 2025
Competing interests
: RPG is a consultant to Antengene Biotech LLC, Ascentage Pharma Group and NexImmune Inc.; Medical Director, FFF Enterprises Inc.; Board of Directors: Russian Foundation for Cancer Research Support; and Scientific Advisory Boards, Nanexa AB and StemRad Ltd.
: The study was approved by the Ethics Committee of Sun Yat-sen University. Subjects gave written informed consent consistent with the precepts of the Declaration of Helsinki.
